Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Rudolph: Nasal Microbiota With Red and Sore Nose [NA]
The clinical trial NCT03073837, sponsored by Kimberly-Clark, has completed evaluating Rudolph: Nasal Microbiota With Red and Sore Nose for d…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Infant Fecal Insult Study [NA]
Clinical trial update indicating completion of an infant dermatitis study sponsored by Kimberly-Clark; phase information is not provided.
-
FDA approval · 2017-08-14FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic Nystatin and Triamcinolone Acetonide Cream under an Original Application by Padagis Israel Pharmaceuticals Ltd. It is…
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Phase 1 Study of Levocetirizine [Phase 1]
Phase 1 study of levocetirizine for dermatitis has completed, sponsored by GlaxoSmithKline.
-
FDA approval · 2017-07-21FDA Approved: FLUOCINONIDE — Original Application (Novel Laboratories, Inc.)
FDA approval for fluocinonide from Novel Laboratories, Inc. as an Original Application (ANDA), representing first-time approval of this gene…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-07-17FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's generic fluocinonide acetonide as an original application (ANDA 202849) for topical tr…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD) [NA]
Completed clinical trial evaluating 3M Cavilon Advanced Barrier Film for treating dermatitis, including incontinence-associated dermatitis, …
-
FDA approval · 2017-05-26FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for betamethasone dipropionate from Sun Pharmaceutical Industries, Inc., authorizing an update to th…
-
FDA approval · 2017-05-24FDA Approved: BETAMETHASONE VALERATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original generic application for Betamethasone valerate. This approval makes the generic …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) [Phase 1]
A Phase 1 trial by GlaxoSmithKline evaluated T-cell responses to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative …
-
FDA approval · 2017-03-20FDA Approved: CLOBETASOL PROPIONATE — Original Application (Northstar Rx LLC)
FDA approved the original application for a generic clobetasol propionate topical corticosteroid, manufactured by Northstar Rx LLC. The appr…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation [Phase 3]
A Phase 3 trial comparing barrier film to standard skin care to prevent dermatitis in women receiving radiation therapy for breast cancer ha…
-
FDA approval · 2017-02-16FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for clobetasol propionate topical corticosteroid from Zydus Lifesciences Limited.
-
FDA label_change · 2017-01-13FDA Approved: CORDRAN — Supplemental Application (Almirall, LLC)
FDA approved a supplemental application for CORDRAN (flurandrenolide) filed by Almirall, LLC, likely affecting labeling.
-
FDA approval · 2017-01-12FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' original ANDA for Triamcinolone Acetonide topical (generic), clearing a new generic product on the mar…
-
FDA approval · 2017-01-11FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone topical generic under an Original Application (ANDA 208163).
-
FDA approval · 2017-01-09FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone as a generic topical corticosteroid under an original ANDA.
-
FDA approval · 2017-01-06FDA Approved: DESOXIMETASONE — Original Application (Saptalis Pharmaceuticals, LLC.)
The FDA approved an original ANDA application from Saptalis Pharmaceuticals for a desoximetasone topical product, a generic corticosteroid f…
-
FDA approval · 2016-12-20FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical antif…
-
FDA approval · 2016-12-13FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.
-
FDA approval · 2016-12-12FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic desoximetasone topical (original application) for relief of inflammatory and pruritic manifestat…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating the efficacy and safety of apremilast in adults with moderate to severe atopic dermatitis completed with results po…
-
FDA approval · 2016-11-07FDA Approved: DESOXIMETASONE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic desoximetasone under an original ANDA, enabling a new topical corticosteroid product to reach the mark…
-
FDA approval · 2016-10-26FDA Approved: TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA granted approval of a supplemental application for Triamcinolone Acetonide submitted by Sun Pharmaceutical Industries, Inc., resulting i…
-
FDA approval · 2016-10-21FDA Approved: FLUOCINOLONE ACETONIDE TOPICAL — Original Application (Actavis Pharma, Inc.)
FDA approved a generic fluocinonide acetonide topical product under an original application from Actavis Pharma, Inc.